Noncirrhotic hyperammonemia after deceased donor kidney transplantation: A case report.
George Z LiMaria C TioLinda M PakJoel KrierJulian L SeifterStefan G TulliusLeonardo V RiellaSayeed K MalekAndrew B StergachisPublished in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2019)
A 72-year-old woman with end-stage kidney disease due to recurrent urinary tract infections and obstructive uropathy of a solitary kidney presented to our hospital for renal transplantation. She underwent successful transplantation of a deceased donor allograft, but developed acute mental status deterioration on the fifth postoperative day. Her serum ammonia was found to be markedly elevated to 447 μmol/L in the setting of normal hepatic function. She was treated with emergent dialysis and empiric antibiotics targeting urea-splitting organisms, and ultimately made a full neurologic recovery with stable renal allograft function. Noncirrhotic hyperammonemia (NCH) is an exceedingly rare clinical entity but seems to have a predilection for patients who have undergone solid organ transplantation. This report emphasizes the importance of rapid diagnosis and initiation of treatment for NCH, which is associated with a high rate of mortality and irreversible neurological morbidity. We outline the successful workup and management approach for this patient.
Keyphrases
- kidney transplantation
- end stage renal disease
- urinary tract infection
- chronic kidney disease
- peritoneal dialysis
- newly diagnosed
- ejection fraction
- patients undergoing
- healthcare
- liver failure
- mental health
- cardiovascular events
- cell therapy
- respiratory failure
- prognostic factors
- stem cells
- risk factors
- intensive care unit
- bone marrow
- drug induced
- brain injury
- patient reported outcomes
- acute respiratory distress syndrome
- blood brain barrier
- subarachnoid hemorrhage
- combination therapy
- coronary artery disease
- sensitive detection